Thermo Fisher Scientific introduces the Applied Biosystems™ MagMAX™ Sequential DNA/RNA Kit, a groundbreaking product that consolidates DNA and RNA isolation into a single, efficient workflow. Lab managers in clinical and translational research labs will appreciate the productivity boost and cost savings this innovative kit provides.
By automating sequential DNA and RNA isolation, the MagMAX kit reduces hands-on time and minimizes errors, allowing teams to achieve faster results with fewer resources. Its compatibility with high-capacity samples, up to 15,000 white blood cells per microliter, ensures reliable processing for diverse research needs.
Benefits for Lab Managers
- Increased Efficiency: Consolidates two workflows into one seamless process.
- Preserved Samples: Extracts maximum data from minimal volumes.
- Flexible Scaling: Supports varying sample volumes and throughput.
- Faster Results: Streamlined isolation accelerates time-to-data.
- Space-Saving Design: Compact packaging for easier storage.
Designed for labs focusing on hematological malignancies, the MagMAX kit offers a reliable solution for genomic research while optimizing resources and improving workflow efficiency.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit Thermo Fisher Scientific's website.
